Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by HighteawithIntrepidon Jan 31, 2018 2:43pm
330 Views
Post# 27473185

We are in talks

We are in talksLooks like the guests enjoyed the meal didn’t grasp the
science quite as well as Bio and were in no rush to get
in before we break $4. We are in talks, is-more like
we had a few companies kick the tires but they don’t see
us worth 3 billion. Bottom line great science lousy money 
management, so the market rated the presentation a draw.
But maybe one or two analysts in the room update their 
opinions. So February might bring a bit more recovery.
But definitely another reason to stop smoking and cut back 
on alcohol consumption.
Bullboard Posts